LIFESTANCE HEALTH GROUP INC

NASDAQ: LFST (LifeStance Health Group, Inc.)

最近更新时间: 5天之前, 4:16PM

14.48

0.40 (2.84%)

前收盘价格 14.08
成交量 3,734,270
预期市盈率 (P/E Forward) 61.22
价格/销量 (P/S) 3.32
股市价格/股市净资产 (P/B) 3.59
52周波幅
6.02 (-58%) — 15.66 (8%)
营业毛利率 -2.78%
营业利益率 (TTM) 0.48%
稀释每股收益 (EPS TTM) -0.090
季度收入增长率 (YOY) 10.80%
总债务/股东权益 (D/E MRQ) 33.09%
流动比率 (MRQ) 1.47
营业现金流 (OCF TTM) 126.01 M
杠杆自由现金流 (LFCF TTM) 113.77 M
资产报酬率 (ROA TTM) -0.33%
股东权益报酬率 (ROE TTM) -2.47%

AIStockmoo 评分

1.4
资本回报低于资本成本。资本回报上升。 参考
负债低。盈利能力弱。现金流为正。 参考
来自我们的 AI Insight 报告对预期回报与风险的评估。 参考 NA
相对估值 参考 NA
隐含增长 参考 NA
历史估值 参考 NA
持仓估值 参考 NA
风险溢价 参考 NA
市场估值 参考 NA
过去一年呈上升趋势。股价接近52周高点。 参考
上升趋势:股价位于均线之上,均线向上。股价接近均线。 参考
来自我们对走势图的 AI 技术分析。 参考 NA
K线形态 参考 NA
近期没有目标价,因此依据目标价的调整方向。 参考
近期新闻大多正面。 参考
持仓情绪 参考 NA
机构在最新13F申报中净-0.47%的股份:235家增持,112家减持(截至30 Sep 2026的季度)。 参考
空头持仓从31 Aug到30 Oct 2026变化+0.3%,回补天数4.4天(FINRA)。 参考
内部交易活动 参考 NA
市场环境偏谨慎。 参考
行业表现优于大市。
各支柱方向一致,评分因此加强。
每股盈利逐年上升。近年曾亏损。 参考
高于中期趋势线。 参考
股价高于其52周平均水平。5年来上涨。 参考
短、中、长期趋势均向上。短期动能上升。 参考
股价处于支撑位与阻力位之间。支撑与阻力水平趋升。 参考
最终评分 1.37
全部展开

市场趋势

短期 中期
行业 Medical Care Facilities (US) 混合的 混合的
Medical Care Facilities (全球的) 看涨 混合的
股票 LifeStance Health Group, Inc. 混合的 看涨

相关股票

股票 市值 DY P/E(TTM) P/B 评分
LFST - - - 3.59 1.4
ENSG 10 B 0.15% 26.24 4.17 -0.5
SGRY 3 B - - 2.12 1.9
PNTG 1 B - 34.30 3.34 -1.9
NUTX - - - 2.73 1.6
INNV - - - 5.03 -1.1

LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.

部门 Healthcare
行业 Medical Care Facilities
投资方式 Small Growth
内部持股比例 8.22%
机构持股比例 93.24%

所有权

姓名 日期 持有股份
Summit Partners L P 30 Sep 2026 16,623,824
Silversmith Partners I Gp, Llc 31 Mar 2026 6,157,127

该时间范围内无数据。

该时间范围内无数据。

机构

机构持股比例: 111.96%

持仓变动 机构数 股数
增持 235 60,326,145
减持 112 67,038,049
新建仓 78 6,791,409
清仓 42 1,862,859

来源:经Nasdaq的SEC 13F申报,最新申报截至30 Sep 2026。申报在每季结束后45天内陆续提交。

空头持仓

结算日 股数 回补天数
30 Oct 2026 13,664,933 4.4
15 Oct 2026 13,769,507 4.8
30 Sep 2026 15,508,383 2.6
15 Sep 2026 16,260,201 3.1
31 Aug 2026 13,620,445 4.2
14 Aug 2026 11,424,044 2.0

来源:经Nasdaq的FINRA空头持仓数据,每月公布两次。

12 正面 2 负面 3 中性
日期 类型 细节
13 Nov 2026 Yahoo Finance LifeStance, Private Equity Rollup Turned Organic Growth Stock, Targets A Profound Void
LifeStance stock has doubled this year and analysts foresee big time earnings growth. But "the bar is higher" now.
10 Nov 2026 Yahoo Finance LFST Q3 2026 deep dive: specialty services, clinician expansion, and EHR transition shape outlook
Behavioral health company LifeStance Health (NASDAQ:LFST) announced better-than-expected revenue in Q3 2026, with sales up 25.3% year on year to $455.9 million. On top of that, next quarter’s revenue guidance ($456 million at the midpoint) was surprisingly good and 3.9% above what analysts were…
09 Nov 2026 Yahoo Finance Surging Earnings Estimates Signal Upside for LifeStance Health (LFST) Stock
LifeStance Health Group (LFST) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
09 Nov 2026 Yahoo Finance LifeStance Health Group Announces Pricing of Secondary Public Offering
SCOTTSDALE, Ariz., Nov. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced the pricing of a secondary underwritten public offering of…
09 Nov 2026 Yahoo Finance LifeStance Health Group Announces Launch of Secondary Public Offering
SCOTTSDALE, Ariz., Nov. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced that pursuant to a shelf registration statement filed with…
07 Nov 2026 Yahoo Finance Why LifeStance Health Group (LFST) Moved Today
LifeStance Health Group (LFST) reported third quarter 2026 results that exceeded analyst expectations, along with an increase in full year revenue guidance to a range between US$1.741b and US$1.761b. Over the past year, LifeStance Health Group has shifted from a recovery story into one with clear…
06 Nov 2026 Yahoo Finance What Makes LifeStance Health Group (LFST) a Strong Momentum Stock: Buy Now?
Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.
06 Nov 2026 Yahoo Finance LifeStance Health Group, Inc. (LFST) Hits Fresh High: Is There Still Room to Run?
LifeStance Health (LFST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
06 Nov 2026 Yahoo Finance What LifeStance Health Group (LFST) Said on Its Q3 Earnings Call
LifeStance Health Group (NASDAQ:LFST) raised its full-year 2026 outlook after reporting 25% third-quarter revenue growth, driven by more patient visits and higher revenue per visit. The mental health care provider also said its planned electronic health record transition could temper revenue growth…
05 Nov 2026 Yahoo Finance LifeStance Health Group Inc (LFST) (Q3 2026) Earnings Call Highlights: Revenue Jumps 25% as ...
LifeStance Health Group Inc (LFST) posted $456 million in revenue with 70% adjusted EBITDA growth, raised full-year guidance, and flagged a temporary EHR-related growth impact for 2027…
05 Nov 2026 Yahoo Finance LifeStance (LFST) Q3 2026 Earnings Call Transcript
Revenue rose 25% as management lifted its full-year outlook across core metrics.
05 Nov 2026 Yahoo Finance Oscar Slips As LifeStance, HCA Climb On Earnings, Payment Hike
Investors are betting that Democrats will be good for healthcare spending.
05 Nov 2026 Yahoo Finance LifeStance Health Group (LFST) Tops Q3 Earnings and Revenue Estimates
LifeStance Health (LFST) delivered earnings and revenue surprises of +100.00% and +6.31%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
05 Nov 2026 Yahoo Finance LifeStance Health: Q3 Earnings Snapshot
(AP) — LifeStance Health Group Inc. (LFST) on Thursday reported third-quarter net income of $22…
05 Nov 2026 Yahoo Finance LifeStance Health Group (NASDAQ:LFST) reports bullish Q3 2026, stock soars
Behavioral health company LifeStance Health (NASDAQ:LFST) reported Q3 2026 results exceeding the market’s revenue expectations, with revenue rising 25.3% year on year to $455.9 million. In addition, next quarter’s revenue guidance ($456 million at the midpoint) was a positive surprise, coming in…
05 Nov 2026 Yahoo Finance LifeStance Reports Strong Third Quarter 2026 Financial Results and Raises Full Year Outlook
SCOTTSDALE, Ariz., Nov. 05, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the third quarter ended September 30, 2026. (All results compared to prior-year comparative…
02 Nov 2026 Yahoo Finance LifeStance Health Flirts With Latest Buy Point Despite Ongoing Stock Market Weakness
LifeStance Stock is flirting with its latest buy point amid the ongoing stock market weakness. Its RS line hit a new high last week.
29 Oct 2026 Yahoo Finance Teladoc Soars 11% on Q3 Beat and Raised Outlook as “Insurance Revenue Exceeded Our Expectations”
Key TakeawaysTeladoc Health rose 11% after its third-quarter adjusted EBITDA beat guidance, rising 14% to $79. 4 million.
29 Oct 2026 Yahoo Finance /C O R R E C T I O N - LifeStance Health/
LifeStance Health, one of the nation's largest providers of outpatient mental healthcare, is expanding access to two specialty services for treatment-resistant depression – esketamine1 (Spravato) and transcranial magnetic stimulation2 (TMS) – as separate analyses show meaningful reductions in…
显示更多

技术形态 中期

趋势排列
斜率
入场位置
成交量
上升趋势:股价位于均线之上,均线向上。股价接近均线。
最近支撑: 13.40 – 13.92 · 强
最近阻力: 15.50 – 15.82 · 中等

AI 技术分析

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

风险 / 回报
TP1:
TP2:

以入场价计算,止损的亏损相对每个目标价的盈利。通常追求 2 或以上的比率。

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2026 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票